KemPharm Converting FDA Complete Response Letters Into New Opportunities
KemPharm’s experience in reworking product NDAs following FDA Complete Response Letters has created a unique capability within the company, and...
Stay updated with breaking news from Ben Comer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KemPharm’s experience in reworking product NDAs following FDA Complete Response Letters has created a unique capability within the company, and...
Albireo Pharma CEO Ron Cooper discusses the company’s three approaches to commercializing orphan drugs globally, and how to go from topline...
When CEO Avanish Vellanki founded and incorporated Rain Therapeutics on his living room couch in the spring of 2017, there was no drug in...
Three organizations pursuing three different strategies for new drug development have one thing in common: optimism about the future of treatments...
An outspoken champion of gender equity and diversity in the workplace, Arcellx CEO Rami Elghandour aims to put the company’s controllable CAR-T...